Congenital Diaphragmatic Hernia Clinical Trial
Official title:
Milrinone in Congenital Diaphragmatic Hernia
Infants with congenital diaphragmatic hernia (CDH) usually have pulmonary hypoplasia and persistent pulmonary hypertension of the newborn (PPHN) leading to hypoxemic respiratory failure (HRF). Pulmonary hypertension associated with CDH is frequently resistant to conventional pulmonary vasodilator therapy including inhaled nitric oxide (iNO). Increased pulmonary vascular resistance (PVR) can lead to right ventricular overload and dysfunction. In patients with CDH, left ventricular dysfunction, either caused by right ventricular overload or a relative underdevelopment of the left ventricle, is associated with poor prognosis. Milrinone is an intravenous inotrope and lusitrope (enhances cardiac systolic contraction and diastolic relaxation respectively) with pulmonary vasodilator properties and has been shown anecdotally to improve oxygenation in PPHN. Milrinone is commonly used during the management of CDH although no randomized trials have been performed to test its efficacy. Thirty percent of infants with CDH in the Children's Hospital Neonatal Database (CHND) and 22% of late-preterm and term infants with CDH in the Pediatrix database received milrinone. In the recently published VICI trial, 84% of patients with CDH received a vasoactive medication. In the current pilot trial, neonates with an antenatal or postnatal diagnosis of CDH will be randomized to receive milrinone or placebo to establish safety of this medication in CDH and test its efficacy in improving oxygenation.
This is a pilot trial to determine if milrinone infusion in neonates ≥ 36 weeks' postmenstrual age (PMA) at birth with CDH would lead to an increase in PaO2 with a corresponding decrease in OI by itself or in conjunction with other pulmonary vasodilators such as iNO at 24 h post-infusion. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05100693 -
Smart Removal for Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT05450653 -
Trial of FETO for Severe Congenital Diaphragmatic Hernia
|
N/A | |
Terminated |
NCT04140669 -
Automated Myocardial Performance Index Using Samsung HERA W10
|
||
Recruiting |
NCT05201144 -
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH)
|
Phase 2 | |
Not yet recruiting |
NCT06281717 -
Fetal Endotracheal Occlusion (FETO) in Fetuses With Severe Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT04429750 -
Intact Cord Resuscitation in CDH
|
N/A | |
Recruiting |
NCT03750266 -
3D Animation and Models to Aid Management of Fetal CDH
|
||
Not yet recruiting |
NCT05421676 -
Fetal Endoscopic Tracheal Occlusion for CDH (CDH)
|
N/A | |
Completed |
NCT01243229 -
Genetic Analysis of Congenital Diaphragmatic Disorders
|
||
Recruiting |
NCT04583644 -
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH)
|
N/A | |
Completed |
NCT03314233 -
Delayed Cord Clamping for Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT04114578 -
Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia
|
||
Completed |
NCT03666767 -
Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries
|
||
Recruiting |
NCT02986087 -
Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia
|
N/A | |
Recruiting |
NCT03674372 -
Fetoscopic Endoluminal Tracheal Occlusion
|
N/A | |
Active, not recruiting |
NCT05839340 -
Neurally Adjusted Ventilatory Assist for Neonates With Congenital Diaphragmatic Hernias
|
N/A | |
Enrolling by invitation |
NCT05962346 -
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
|
N/A | |
Withdrawn |
NCT04186039 -
Functional Evaluation of the Fetal Lung by Functional Magnetic Resonance Imaging - Blood Oxygenation Level Dependent (MRI-BOLD), in Congenital Diaphragmatic and Parietal Malformations
|
N/A | |
Unknown status |
NCT01302977 -
Fetal Tracheal Occlusion in Severe Diaphragmatic Hernia: a Randomized Trial
|
Phase 2 | |
Recruiting |
NCT03179371 -
Proteomic Profiling for Congenital Diaphragmatic Hernia
|